Farallon Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-250,625
Closed -$44.1M 248
2022
Q3
$44.1M Sell
250,625
-353,158
-58% -$72.3M 0.24% 76
2022
Q2
$122M Buy
603,783
+103,247
+21% +$22M 0.66% 45
2022
Q1
$113M Buy
500,536
+18,443
+4% +$4.34M 0.55% 45
2021
Q4
$130M Buy
482,093
+67,859
+16% +$16.8M 0.65% 41
2021
Q3
$100M Buy
+414,234
New +$104M 0.47% 54

Other funds holding LH

Farallon Capital Management's LH Position: Q4 2022 in Review

Farallon Capital Management sold out of Labcorp (LH) in Q4 2022, closing a stake of 250,625 shares — an estimated $44.1M sold.

Farallon Capital Management first reported a position in LH in Q3 2021 and held it in 5 quarters. The position peaked at $130M in Q4 2021. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Farallon Capital Management reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Farallon Capital Management sold 250,625 Labcorp shares in Q4 2022, an estimated $44.1M.
  • Farallon Capital Management first reported a position in Labcorp in Q3 2021 and held it in 5 quarters.
  • Farallon Capital Management's Labcorp position peaked at $130M in Q4 2021.
  • 970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.